Chugai Pharmabody Research Pte. Ltd. ('CPR') was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Biopolis in
Singapore
, it aims to generate new antibody drugs based on Chugai's proprietary antibody engineering technologies, such as recycling antibody®, sweeping antibody®, bispecific antibody, various Fc engineered antibodies, and other new antibody engineering technologies that are under development. Overview You will support the Pharmacology unit by performing experiments, contributing to cell-based screening, molecular biology workflows, and routine lab operations. You will follow SOPs, maintain accurate records, uphold data quality, and collaborate primarily within Pharmacology and, as projects require, with colleagues in other units. You communicate clearly, collaborate well in multidisciplinary settings, and take ownership of assigned...